Skip to main content

Mara Becker

Professor of Pediatrics
Pediatrics, Rheumatology
DUMC 3611, Durham, NC 27710
117B Davison Building, Dean's Suite, Durham, NC 27710

Selected Grants


Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2021 - 2026

Optimal Dosing for Biologic Agents in Obese Patients with Rheumatoid and Juvenile Arthritis

ResearchAdvisor · Awarded by National Institutes of Health · 2020 - 2025

PTN 2.0 TO 6 Down Syndrome Extension

Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025

PTN 2.0 TO 6 Down Syndrome Extension

ResearchPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025

Clinical Pharmacokinetics and Safety Trials in Down Syndrome

Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025

Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2021 - 2026

Optimal Dosing for Biologic Agents in Obese Patients with Rheumatoid and Juvenile Arthritis

ResearchAdvisor · Awarded by National Institutes of Health · 2020 - 2025

PTN 2.0 TO 6 Down Syndrome Extension

Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025

PTN 2.0 TO 6 Down Syndrome Extension

ResearchPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025

Clinical Pharmacokinetics and Safety Trials in Down Syndrome

Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2025

Identifying Pharmacogenomic Predictors of Methotrexate Response and Metabolite Biotransformation in JIA

ResearchPrincipal Investigator · Awarded by Cincinnati Children's Hospital Medical Center · 2017 - 2023

PTN 2.0- TO 3 - Option 3 - BPCA Concept Development and Clinical Trial Readiness Support

ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2021 - 2022

HCQ Pharmacokinetics in Pediatric Lupus

ResearchMentor · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2019 - 2020

External Relationships


  • American College of Rheumatology
  • Canadian Arthritis Society
  • Childhood Arthritis and Rheumatology Research Alliance
  • Doris Duke Charitable Foundation
  • Food and Drug Administration
  • American College of Rheumatology
  • Canadian Arthritis Society
  • Childhood Arthritis and Rheumatology Research Alliance
  • Doris Duke Charitable Foundation
  • Food and Drug Administration
  • Patient Centered Outcomes Research Institute
  • The Duke Endowment

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.